Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Cardinal Health, Inc.
The company shared information publicly (Regulation FD). An 8-K is the notice a US public company must file within four business days of a major event.
cardinalhealth.comAI Executive Summary
AI-powered analysis of 8-K filing content
Cardinal Health extended its pharmaceutical distribution agreements with CVS Health through June 2032, reinforcing a critical long-term partnership and reaffirming fiscal 2027 EPS guidance of $12.40-$12.60.
Key Takeaways
Binding letter of intent extends Cardinal Health's pharmaceutical distribution agreement with CVS Health until June 2032, providing multi-year revenue visibility
Company reaffirmed fiscal 2027 non-GAAP EPS guidance range of $12.40 to $12.60 and long-term EPS growth guidance of 12% to 14%
1 more takeaway
Filing Overview
What This Means
Cardinal Health, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.